Pomalidomide 4'-PEG3-acid

CAS : 2138440-82-9

Ref. 3D-NKD44082

Informations sur le produit

• Nom: Pomalidomide 4'-PEG3-acid

Description

Pomalidomide 4'-PEG3-acid is a pegylated form of pomalidomide, a medication used for the treatment of multiple myeloma. Pegylation involves attaching polyethylene glycol (PEG) molecules to a drug, which can enhance its therapeutic properties. In this case, Pomalidomide 4'-PEG3-acid is a PEG product that contains an amido PEG linker and an acid PEG moiety.

The pegylation of pomalidomide offers several advantages. It prolongs the drug's circulation time in the body, leading to improved bioavailability and reduced dosing frequency. Additionally, pegylation can enhance the drug's stability and reduce immunogenicity.

Pomalidomide 4'-PEG3-acid is specifically designed to enhance the pharmacokinetic profile of pomalidomide. The amido PEG linker ensures a stable attachment between pomalidomide and PEG, while the

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 477.5 g/mol
• Formule: C₂₂H₂₇N₃O₉
• Degré de pureté: Min. 95%